Table 2 ESR, and levels of CRP and PTX3 in TA patients
From: Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis
| Â | Erythrocyte sedimentation rate, mm/h | C-reactive protein, mg/l | Pentraxin-3, ng/ml |
|---|---|---|---|
Class of vascular involvement | Â | Â | Â |
1 (n = 4) | 28, 34 (4 to 44) | 8.3, 6.0 (2.7 to 19) | 5.5, 6.2 (2.9 to 6.7) |
2A (n = 4) | 15, 17 (7 to 22) | 3.0, 1.0 (0.1 to 11) | 15, 6.8 (6.2 to 44) |
2B (n = 3) | 33, 33 (29 to 38) | 17, 12 (1.2 to 37) | 5.3, 5.0 (3.9 to 7.0) |
3 (n = 1) | 4.0 | 2.0 | 6.3 |
4 (n = 0) | NA | NA | NA |
5 (n = 30) | 21, 15 (1 to 78) | 5.5, 1.9 (0.1 to 40) | 8.2, 5.1 (3.0 to 5.1) |
Presence of aneurysms (n = 16) | 23, 15 (1 to 78) | 5.7, 2.7 (0.3 to 40) | 6.6, 5.8 (1.3 to 23) |
Absence of aneurysms (n = 26) | 20, 16 (2 to 68) | 6.9, 1.2 (0.1 to 37) | 11, 5.0 (2.2 to 55) |
Active (NIH criteria n = 12) | 34, 38 (3 to 73) | 12, 8.6 (0.3 to 40) | 12, 6.9 (2.2 to 55) |
Inactive (NIH criteria n = 30) | 16, 12 (1 to 78) | 3.5, 1.9 (0.1 to 19) | 7.1, 5.0 (1.3 to 44) |